CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that members of the management team will present at the Wedbush PacGrow Healthcare Conference on August 17, 2016 at 9:10 am ET. The conference is being held August 16-17, 2016 at the Le Parker Meridien in New York.
